Ucsf Center For Tuberculosis 1

1. Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis
2. Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial
1